tm
Seeing Is Believing
tm
Seeing Is Believing
DAWN is currently covered by 6 analysts with an average price target of $21.92. This is a potential upside of $14.62 (200.27%) from yesterday's end of day stock price of $7.3.
Day One Biopharmaceuticals's activity chart (see below) currently has 72 price targets and 65 ratings on display. The stock rating distribution of DAWN is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 2.78% with an average time for these price targets to be met of 75.33 days.
Highest price target for DAWN is $32, Lowest price target is $16, average price target is $25.8.
Most recent stock forecast was given by AMI FADIA from NEEDHAM on 06-Aug-2025.
Currently out of the existing stock ratings of DAWN, 12 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$16
$8.56 (115.05%)
$27
2 months 29 days ago
(06-Aug-2025)
0/18 (0%)
$10.2 (175.86%)
Buy
$29
$21.56 (289.78%)
$34
5 months 22 days ago
(13-May-2025)
0/5 (0%)
$22.67 (358.14%)
Buy
$27
$19.56 (262.90%)
$43
7 months 10 days ago
(25-Mar-2025)
0/6 (0%)
$18.72 (226.09%)
Buy
$32
$24.56 (330.11%)
$32
8 months 9 days ago
(26-Feb-2025)
0/7 (0%)
$22.13 (224.21%)
Buy
$25
$17.56 (236.02%)
$24
9 months 28 days ago
(07-Jan-2025)
1/4 (25%)
$12.6 (101.61%)
678
What is DAWN (Day One Biopharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on DAWN (Day One Biopharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on DAWN (Day One Biopharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on DAWN (Day One Biopharmaceuticals)?
Which analyst is the currently most bullish on DAWN (Day One Biopharmaceuticals)?
Which analyst is the currently most reserved on DAWN (Day One Biopharmaceuticals)?
